Overview Business review Financial review Governance Financial statements and other information Reed Elsevier Annual Reports and Financial Statements 2013 193 16 Principal joint ventures % holding Reed Elsevier Group plc Incorporated and operating in Great Britain 18,385 ordinary R shares 13 Strand 18,385 ordinary E shares 100% London WC2N 5JR 100,000 7.5% cumulative preference non voting shares Holding company for operating businesses involved in science & medical, risk management, legal and business publishing and organisation of trade exhibitions Equivalent to a 50% equity interest Elsevier Reed Finance BV Incorporated in the Netherlands 133 ordinary R shares Radarweg 29 205 ordinary E shares 100% 1043 NX Amsterdam, the Netherlands Holding company for financing businesses Equivalent to a 61% equity interest The R shares in Reed Elsevier Group plc and Elsevier Reed Finance BV and the nonvoting preference shares in Reed Elsevier Group plc are owned by Reed Elsevier PLC.
In addition, Reed Elsevier NV holds shares with special dividend rights in Reed Elsevier Overseas BV, a subsidiary of Reed Elsevier Groupplc with registered offices in Amsterdam.
These shares are included in the amount shown under investments in joint ventures andenable Reed Elsevier NV to receive dividends from companies within the same tax jurisdiction.
A list of companies within Reed Elsevier is filed with the Amsterdam Chamber of Commerce in the Netherlands.
17 Approval of financial statements The consolidated financial statements were signed and authorised for issue by the Board of Directors on 26 February 2014.
A J Habgood D J Palmer Chairman of the Board Chief Financial Officer 29275 SAS p182-193 CONSOLID INC STATEMNT.
